2005 Computational Chemistry Pharmaceuticals 
Sygnature Discovery
MARCH 24, 2022
Sygnature’s first logo Led by founder Simon Hirst, this ambitious small Chemistry group hit the ground running, quickly developing strong relationships with customers and expanding into other scientific specialities like Computational Chemistry. Back to Lynette, though.
Drug Target Review
SEPTEMBER 20, 2023
Training AI/ML tools to predict results of otherwise complex and time-consuming calculations is gaining traction in pharmaceutical R&D. To really benefit from AI, the pharmaceutical industry must be more open to data sharing. Matthew subsequently put his computational chemistry skills to use in the defence sector.
Expert insights. Personalized for you.
52 
Let's personalize your content